USD
+$0.00
(+0.00%
)At Close (As of Oct 21, 2025)
$656.61M
Market Cap
-
P/E Ratio
-0.57
EPS
$20.05
52 Week High
$11.70
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Operating Cashflow | -$12M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $4.4M |
Capital Expenditures | $10M |
Change In Receivables | - |
Change In Inventory | -$8M |
Profit Loss | - |
Cashflow From Investment | $13M |
Cashflow From Financing | $2M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $2.2M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$31M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Si-Bone, Inc. is a leading medical device company specializing in the development of innovative implantable solutions for the surgical treatment of sacropelvic disorders. Headquartered in Santa Clara, California, the firm operates both in the United States and internationally, aiming to enhance patient outcomes through its advanced technology portfolio. With a focus on addressing unmet clinical needs in spine surgery, Si-Bone is well-positioned to leverage the growing demand for minimally invasive procedures in the orthopedic market.